Penumbra (PEN) Non-Current Deffered Revenue (2015 - 2018)
Penumbra's (PEN) quarterly Non-Current Deffered Revenue came in at $7.6 million in Q4 2018, up 22.37% year-on-year from $6.2 million in Q4 2017, and up 1.01% on a QoQ basis from $7.5 million in Q3 2018.
Penumbra (PEN) Non-Current Deffered Revenue (2015 - 2018) Analysis & Trends
Penumbra (PEN) has 4 years of Non-Current Deffered Revenue data on file, last reported at $7.6 million in Q4 2018.
- On a quarterly basis, Non-Current Deffered Revenue rose 22.37% year-over-year to $7.6 million in Q4 2018; TTM through Dec 2018 was $7.6 million, a 22.37% increase from a year earlier, with the FY2018 full-year figure at $7.6 million, up 22.37% from the prior year.
- Non-Current Deffered Revenue for Q4 2018 stood at $7.6 million, up from $7.5 million in the prior quarter.
- Over the last five years, Non-Current Deffered Revenue for PEN reached as high as $7.6 million in Q4 2018 and fell as low as $1.5 million in Q4 2015.
- Historically, Non-Current Deffered Revenue has averaged $6.0 million across 4 years, with a median of $6.1 million in 2017.
- Across the five-year window, Non-Current Deffered Revenue soared 236.4% in 2016 and grew 21.96% in 2017, its largest moves.
- Year by year, Non-Current Deffered Revenue stood at $1.5 million in 2015, then surged by 236.4% to $5.1 million in 2016, then grew by 21.96% to $6.2 million in 2017, then rose by 22.37% to $7.6 million in 2018.
- Per Business Quant data, the three most recent Non-Current Deffered Revenue figures were $7.6 million in Q4 2018, $7.5 million in Q3 2018, and $7.4 million in Q2 2018.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 512.79 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Penumbra | 12.48 Bn | 11.87 Bn | 253.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 7.59 Mn |
| Sep 30, 2018 | 7.51 Mn |
| Jun 30, 2018 | 7.43 Mn |
| Mar 31, 2018 | 7.35 Mn |
| Dec 31, 2017 | 6.20 Mn |
| Sep 30, 2017 | 6.07 Mn |
| Jun 30, 2017 | 5.68 Mn |
| Mar 31, 2017 | 5.50 Mn |
| Dec 31, 2016 | 5.08 Mn |
| Dec 31, 2015 | 1.51 Mn |